|
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - April 2022
Racism: The Hidden Driver of HIV, Key Focus of Iris House Women’s Summit
NEW YORK--(BUSINESS WIRE)-- April 29, 2022 -- New York-based Iris House, an affiliate of AIDS Healthcare Foundation, will host its annual Women as the Face of AIDS Summit on Monday, May 2, 2022 at Bethel Gospel Assembly, 2-26 East 120th Street (between 5th and Madison Ave), while also allowing attendance virtually. Now in its 17th year, the 2022 Summit is themed, “Racism: The Hidden Driver of HIV” and will feature renowned American sociologist and scholar of urban poverty, Dr. Celeste Watkins-Hayes, Director of the Center for Racial Justice at the University of Michigan, and author of Remaking a Life: How Women Living with HIV/AIDS Confront Inequality (2019, University of California Press).
New York-based Iris House, an affiliate of AIDS Healthcare Foundation, will host its 17th Annual Women as the Face of AIDS Summit, on Monday, May 2, 2022 at 11:00am. The first summit to be presented since 2019, the organization will offer a hybrid model of the program to allow for in-person and virtual participation. The in-person event will take place at Bethel Gospel Assembly, 2-26 East 120th Street, New York.
I Am Now Officially Participating in HIV Cure Research—And You Can Too!
April 29, 2022 - Tim Murphy - There’s a special kind of HIV cure research going on at the Ragon Institute in Cambridge, Massachusetts. Scientists there are collecting blood samples from folks who’ve been on HIV treatment for 15 years or longer. They’ll analyze the samples to determine if these folks are good candidates to do an HIV treatment interruption study with a lofty goal: to see if, by this point, people’s own immune systems have developed the ability to control HIV without meds.
Read more...
MY HERO GALA COMMEMORATES 25 YEARS OF SAVING LIVES
NEW YORK, UNITED STATES, April 29, 2022 /EINPresswire.com/ -- The AFA and AFL My Hero Gala celebration commemorates AID FOR AIDS’ 25th Anniversary and the resilience, ingenuity and empathy of Heroes who work to save lives.
AID FOR AIDS (AFA) and AID FOR LIFE (AFL) are preparing for a spectacular My Hero Gala (MHG) celebration, Tuesday, May 3, 2022, commemorating AID FOR AIDS’ 25th Anniversary. Being held at New York City’s iconic American Museum of Natural History, the event also marks the first in-person My Hero Gala since 2019 due to the COVID-19 pandemic.
Canadian Blood Services to remove eligibility criteria specific to men who have sex with men
April 28, 2022 (OTTAWA) - Canadian Blood Services is pleased to share that Health Canada has approved our request to remove eligibility criteria specific to men who have sex with men and instead focus on sexual behaviour associated with higher risk of infection among all donors.
UNICEF and MAC Viva Glam Boost Efforts to Fight HIV/AIDS
April 28, 2022 - By
Rosemary Feitelberg - AIDS remains the leading cause of death of women of reproductive age.
Strengthening a 19-year partnership with UNICEF, MAC Viva Glam is donating $1.5 million to the organization’s work that helps women and children. They have ramped up efforts to continue to help reduce the transmission of HIV from mothers to babies and the stigma associated with the disease.
Read more...
Alumni Association names Texas State’s most outstanding senior for 2022
April 28, 2022 - Texas State University - Lauren Green is the recipient of the 2022 LBJ Outstanding Senior Student Award presented annually by the Texas State University Alumni Association.
This award is named in honor of Distinguished Alumnus and 36th President of the United States, Lyndon B. Johnson, and recognizes graduating seniors who have shown outstanding leadership, character, campus and community involvement, and academic success.
NDP statement on the removal of the blood ban
April 28, 2022 - The NDP Critic and Deputy Critic for 2SLGBTQI+ Rights, Randall Garrison and Blake Desjarlais, made the following joint statement:
“The news today that, after years of delay, the government is finally allowing men who have sex with men to donate blood is a long-overdue victory for men who have sex with men, community members and allies who have worked tirelessly for years to push the government to act.
Read more...
Canadian Blood Services to end blood ban for men who have sex with men
28 April 2022 - Andy Carstens - Shift comes after 'countless hours' of work by advocates
Canadian Blood Services says Health Canada has approved its request to end the policy that restricts men who have sex with men from donating blood for three months after being sexually active.
Canadian Blood Services asked Health Canada to allow it to scrap questions about gender or sexuality, basing screening on higher-risk sexual behaviour such as anal sex instead.
Read more...
ECDC Publishes Rapid Risk Assessment - Increase in severe acute hepatitis cases of unknown aetiology in children
28 April 2022 - Following the initial report of an increase of severe acute hepatitis cases of unknown aetiology among previously healthy children by the United Kingdom on 5 April 2022, and as of 20 April 2022, 111 cases, aged 10 and under have been identified in that country. As of Wednesday, 27 April 2022, there are approximately 55 cases reported from across the EU/EEA countries (Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Norway, Poland, Romania, Spain). Sporadic cases have been reported from other countries around the world (Canada, Israel, Japan, USA).
Today ECDC has published its Rapid Risk Assessment Increase in severe acute hepatitis cases of unknown aetiology in children, which details the event background, epidemiological investigations until now and options for response for the EU/EEA countries.
American Gene Technologies Launches “The Cure Chronicles” Video Series
“The Cure Chronicles” presents thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working toward ending the HIV epidemic.
April 28, 2022 - American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, has launched a video series showcasing compelling HIV community conversations: The Cure Chronicles, hosted by the company’s CEO Jeff Galvin.
With more than 37 million people in the world living with HIV/AIDS, American Gene Technologies is working hard to develop a cure. The company is in a clinical trial for a single-infusion gene therapy (AGT103-T) to return people living with HIV to a normal life.
The COVID-19 pandemic disrupted HIV prevention and care in Barcelona, but new cases and viral loads didn’t increase
28 April 2022 - Andy Carstens - In-person healthcare visits related to HIV prevention and care decreased in number at the largest HIV care centre in Spain as a result of lockdowns during the COVID-19 pandemic. While chlamydia and gonorrhoea cases surged in 2020 compared to 2019, new HIV cases decreased by 28%. But the new HIV cases were more advanced, according to the study published in AIDS, suggesting that limited access to healthcare may have delayed patients’ HIV diagnoses.
Read more...
Scientists prove diseased blood vessels communicate with the brain
April 27, 2022 - An international team which includes University of Manchester scientists has for the first time demonstrated that nerve signals are exchanged between clogged up arteries and the brain.
Magic Johnson Thanks Dr. Fauci For Helping Him With HIV Diagnosis | The View
April 27, 2022 - The basketball legend tells “The View” why he wanted to make his docuseries “They Call Me Magic” and how he’s changed the stigma surrounding HIV.
LSU Health Cancer Center Funded to Enhance Research Capacity at Tanzania’s Major Cancer Institute
April 27, 2022 - LSU Health New Orleans’ Stanley S. Scott Cancer Center has been awarded $1.5 million over five years to increase the number of trained cancer researchers in Tanzania and prepare them for the future of HIV-associated cancer diagnostics and research in cancer genomics and therapy. It will support the development of the Tanzania AIDS Malignancies Training and Research Program at the Ocean Road Center Cancer Institute (ORCI), the major cancer research institution in Tanzania. The funding was awarded by the National Institutes of Health’s Fogarty International Center, National Cancer Institute (under Award Number D43 TW012277) and the National Institute of Child Health and Human Development.
The future of mRNA-based HIV vaccines is about more than speed
April 27, 2022 - By Micheal Dumiak - IAVI Report
Right now in vaccine research, mRNA has the momentum.
For HIV, there are currently several formulations of experimental vaccines in early-stage human clinical trials. Apart from some overlap in strategy, they have one main thing in common — they rely on mRNA.
Read more...
Broadly Neutralizing Antibodies Delay HIV Rebound
April 27, 2022 - By Liz Highleyman - A combination of two antibodies, dubbed 3BNC117 and 10-1074, maintained viral suppression for a year in two people.
A combination of two broadly neutralizing antibodies (bnAbs) led to prolonged viral suppression after stopping HIV treatment, according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2022) and recently published in Nature. While this study was small, the findings suggest bnAbs could one day be a component of a combination HIV cure strategy.
Read more...
85,000+ HIV cases due to unsafe sex during Lockdown
Apr 27, 2022 - Amarjeet Singh - BHOPAL: When the entire country was locked down due to Covid Covid-19 in 2020-21, more than 85,000 people across India got infected with HIV due to unprotected sex, reveals data under RTI Act.
Read more...
AIDS Memorial Quilt Still Filled With New Names 35 Years Later
April 26, 2022 - By Lindsey Theis
- More than 36 million people have died from HIV/AIDS since the start of AIDS epidemic. An international tribute turns 35 this year.
Some fight with anger, others with love. The keepers of the AIDS Memorial Quilt fight with a needle and thread. This year marks the quilt's 35th anniversary.
It's a living tribute to people who've died from HIV/AIDS — a disease that attacks the body's immune system.
Read more...
Inaugural IU National HIV Conference brings together experts across disciplines
BLOOMINGTON, Ind. - April 26, 2022 - Indiana University will host the first IU National HIV Conference, "Stepping into the 5th Decade: Evolving Our Response to HIV," June 8 to 11 in Indianapolis.
Hosted by the Office of the Vice President for Diversity, Equity and Multicultural Affairs, the conference will include nationally recognized keynote speakers, workshops, poster sessions, and a health and wellness fair that provides testing and health services for the public.
Buckle up! The ‘Staley vs Gilead’ lawsuit could cost Big Pharma billions.
April 26, 2022 - By Mark S. King - This is big news indeed. Pay attention.
The latest twist in the Staley vs. Gilead lawsuit could signal very bad things for Gilead Sciences and Janssen Pharmaceuticals. As the case barrels forward (a jury date is set for March 2023), it could eventually cost Big Pharma billions of dollars in profits that the lawsuit contends has been the result of illegally shaking down people living with HIV and our insurers.
Justice Department sues Indiana town for rejecting man for police job because he has HIV
April 26, 2022 - Rae Johnson - The Justice Department is suing the southern Indiana town of Clarksville, alleging its police department denied a job to a man because he has HIV.
Read more...
A national recruitment strategy for HIV-serodiscordant partners living in Canada for the Positive Plus One study: a mixed-methods study
26 April 2022 - BMC Public Health - Abstract
Background
With the recent shift in focus to addressing HIV risk within relationships and couple-based interventions to prevent HIV transmission, successful recruitment of individuals involved in HIV-serodiscordant relationships is crucial. This paper evaluates methods used by the Positive Plus One (PP1) study to recruit and collect data on a diverse national sample of dyads and individuals involved in current or past HIV-serodiscordant relationships, discusses the strengths and limitations of the recruitment approach, and makes recommendations to inform the interpretation of study results and the design of future studies.
Getting the Word Out
APRIL 25, 2022 - By Hank Trout, MA - In the early years of the epidemic, putting accurate, reliable, non-judgment information into people’s hands was a powerful tool against the spread of HIV.
Getting the word out — compiling scientifically accurate, nonjudgmental information about HIV; how it is transmitted, from whom and to whom; how it is not transmitted; how transmissions can be prevented; and how it can be treated, and getting that information into the hands of people living with or at risk of acquiring the virus — became one tool in combatting the misinformation and stigma surrounding HIV/AIDS. With the advent of the Internet, disseminating information became really easy — with just a few keystrokes, one can reach untold thousands of people with a single Tweet or posting on Facebook or Instagram. But in the early, pre-Internet years of the pandemic, we relied on the technology that was available at the time: the telephone and the printing press.
Read more...
From Hotline to Online
APRIL 25, 2022 - By Emily Land, MA - Awe-inspiring efforts by early AIDS volunteers and staff made it possible to get the word out about HIV treatment, prevention, and care.
In the early years of the AIDS epidemic, it wasn’t always easy to get accurate, timely information about HIV treatment, prevention, and health. In the very early years, good information was hard to come by simply because not much was known–by anyone–about the virus that was causing AIDS. In later years, misinformation about the virus and treatments became entangled in difficult-to-understand medical truths about HIV and AIDs.
Read more...
Over 17 lakh people contracted HIV in India in last 10 years by unprotected sex: RTI reply
APRIL 24, 2022 - The number of people contracting HIV (human immunodeficiency virus) in the last 10 years has come down significantly.
Over 17 lakh people contracted HIV in the country in the last 10 years due to unprotected intercourse, according to the data provided by National AIDS Control Organization in response to an RTI query.
Read more...
AHF and AIDS Taskforce of Greater Cleveland Oppose Discriminatory Ohio Legislation
Los Angeles, Calif. - April 23, 2022 - AIDS Taskforce of Greater Cleveland and AIDS Healthcare Foundation strongly oppose Ohio’s new proposed legislation prohibiting the discussion of sexual orientation and gender identity in public schools. Limiting, or outright banning such discussion completely undermines the state’s public health and education system.
Rose Walton was a pioneering HIV/AIDS advocate — with a great love story
April 23, 2022 - By Jack Evans - Walton, who died earlier this month at 85, established New York’s first AIDS education and resource center before retiring to Sunset Beach.
In his years presiding over Equality Florida’s annual St. Pete Gala, Todd Richardson has seen events drowned out by attendees’ enthusiasm. But when Rose Walton took the stage in 2015 to receive a Lifetime Achievement Award, nearly 600 people inside the Mahaffey Theater fell silent.
Read more...
ACTG Launches A5383, Clinical Trial Evaluating Potential Immunologic Benefits Of Treating Asymptomatic CMV In People Living With HIV
Los Angeles, Calif. - 22-APR-2022 - The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the initiation of A5383, a clinical trial evaluating whether the anti- cytomegalovirus (CMV) drug letermovir reduces inflammation when given to people who have well-controlled HIV and CMV without symptoms.
Cytokine signature that allows COVID-19 patients with worst prognosis to be spotted early is identified by Italian researchers
April 22, 2022 - New research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April) has identified a panel of cytokines that can help predict which COVID-19 patients are at risk of serious illness and death.
GMHC Has Been Helping People Living with HIV for 40 Years
April 22, 2022 - By Desirée Guerrero - The Gay Men’s Health Crisis has survived since the first days of the HIV epidemic — and is still caring for those who have survived along with it.
The Gay Men’s Health Crisis, now just known as GMHC, is believed to be the first organization to address the HIV epidemic in New York City, when the first cases of a “mysterious new illness” among gay and bisexual men were first identified by health officials in 1981. Though, tragically, we lost countless lives to the virus back in those early days, there are also many others who persevered and survived through those dark times — and who now are aging along with organizations like GMHC.
Read more...
ECCMID returns as hybrid meeting
April 22, 2022 - The European Congress of Clinical Microbiology and Infectious Diseases is taking place for the first time this year as a hybrid meeting with both live and online components. Known commonly as ECCMID, the meeting is being held from April 23 to 26 in Lisbon, Portugal.
Read more...
Ontario Liberals pledge to fully cover medication to prevent, treat HIV
Toronto - April 22, 2022 - The Ontario Liberals are announcing that they would expand universal access to medication to prevent HIV transmission and reduce barriers to gender-affirming surgeries if the party wins the June 2 election.
Leader Steven Del Duca made a slate of announcements today aimed at members of the LGBTQ community.
He says every single person should be “empowered at all times to love and to live as their authentic selves.”
Read more...
Nationwide study of COVID in Denmark shows people with omicron variant 36% less likely to be hospitalised than those with delta variant
April 22, 2022 - Reduced risk of hospitalisation with omicron both among unvaccinated and vaccinated suggest an inherently reduced severity of infections with omicron compared with delta
New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Infectious Diseases shows that people infected with the omicron variant of SARS-CoV-2 are 36% less likely to be hospitalised then those with the delta variant, with the reduced risk observed among both unvaccinated and vaccinated. The study is by Dr Peter Bager, Statens Serum Institut, Copenhagen, Denmark, and colleagues.
PEPFAR Investing US $13 Million to Reach Ukrainians in Need with Life-Saving HIV Treatment
April 21, 2020 - The United States government through the President’s Emergency Plan for AIDS Relief (PEPFAR) is taking decisive steps to reach Ukrainians in need with life-saving HIV medications and services amid the humanitarian crisis caused by the Kremlin’s war on Ukraine. Over the past two months, PEPFAR has invested a total of US $13 million in emergency funding to procure 51 million doses of antiretroviral medications (ARVs), enough to meet the urgent treatment needs of Ukrainians living with HIV for up to a year.
Nearly one in five people with HIV in the UK could have a detectable viral load
21 April 2022 - Gus Cairns - COVID has magnified uncertainty over the true number of people who are not virally suppressed
A model using updated HIV surveillance figures from England had found that at least one in seven people with HIV in England, and possibly as many as one in five, has a detectable and transmissible HIV viral load, compared with a previous estimate of less than one in ten. This is partly due to the effects of the COVID pandemic, the British HIV Association (BHIVA) conference heard yesterday in Manchester.
Read more...
A quarter of 2020 deaths of people with HIV in the UK due to COVID-19
21 April 2022 - Roger Pebody - COVID-19 and non-AIDS cancers were the leading causes of death among HIV-positive people in the UK in 2020, with AIDS and cardiovascular disease also cutting lives short, Dr Sara Croxford of the UK Health Security Agency told the British HIV Conference in Manchester yesterday. Overall, six out of seven deaths were due to non-AIDS causes.
Read more...
Global Fund Urges the World to Boost the Fight Against Malaria as COVID-19 Disruptions, Drug and Insecticide Resistance and New Threats Endanger Progress
GENEVA - 21 April 2022 - Ahead of World Malaria Day, 25 April, the Global Fund calls for renewed commitment in the fight against malaria, a disease that now kills one child every minute. After years of steady declines, malaria cases and deaths are on the rise mainly due to stalled funding and disruptions caused by the COVID-19 pandemic.
In 2020, there were an estimated 241 million malaria cases and 627,000 malaria deaths worldwide. This represents about 14 million more cases in 2020 compared to 2019, and 69,000 more deaths. Approximately two-thirds of these additional deaths were linked to COVID-19 disruptions.
Existing medicines with potential to be repurposed to treat gonorrhoea identified in Portuguese study
April 20, 2022 - Blood pressure drug, chemotherapy drug and anti-malarial all show promise
Work could contribute to a paradigm shift in search for new treatments for STI
New research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal,(23-26 April), has identified several existing medicines with potential to be repurposed to treat gonorrhoea.
Antibody function antibody dependent cellular cytotoxicity (ADCC) may help prevent the transmission of HIV from mother to child during breastfeeding
Boston - APR 20, 2022 - According to new research from Boston Medical Center, the antibody function known as antibody dependent cellular cytotoxicity (ADCC) and the ADCC sensitivity of HIV strains may influence the transmission of HIV from mother to child during breastfeeding. These data imply that enhancing ADCC, through a vaccine, for example, may not be sufficient to prevent transmission because chronically infected individuals can harbor ADCC-resistant strains. Published in JCI Insight, the findings provide novel insights about immunologic characteristics that a vaccine may need to elicit to help block HIV transmission.
A Majority of People With HIV Have Asymptomatic COVID
April 20, 2022 - By Liz Highleyman - The proportion without symptoms was higher than previously seen in many studies of both people with HIV and the general population.
More than half of people living with HIV who acquire SARS-CoV-2, the coronavirus that causes COVID-19, have asymptomatic illness, according to study results presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2022). This suggests that people with well-controlled HIV have COVID-19 outcomes similar to those of HIV-negative people.
Read more...
No strangers to pandemics, HIV and infectious diseases researchers study new ways to treat and prevent viruses
April 19, 2022 - Diseases don’t stop in a pandemic. Neither do our researchers. In this series, we highlight Unity Health research projects that have persisted despite lockdowns, work-from-home arrangements and a global focus on another disease entirely. Here are their stories.
Positive Women Revisited
April 19, 2022 - HIV Legal Network - This year, to mark the 10th anniversary of Positive Women, the HIV Legal Network went back to two of the protagonists featured in the original documentary to understand if and how criminalization was still part of their lives. You can watch Positive Women Revisited (2022) now to hear about what it’s still like to live with the constant fear of prosecution, and why this needs to change for people living with HIV in Canada.
Magic Johnson Shares His Life, From the NBA to HIV, in a New TV Series
APRIL 19, 2022 - By Trent Straube - The four-part docuseries “They Call Me Magic” on Apple TV+ offers an inside look at Magic Johnson and his sports and HIV legacy.
Everyone knows Magic Johnson as an iconic basketball player and one of the most famous faces of the HIV epidemic. But do you know what the man himself thinks about these aspects of his life? Now, you can find out. The legendary Lakers star opens up about his life in They Call Me Magic, a new four-part docuseries that premieres on Apple TV+ Friday, April 22
Read more...
Update: Hepatitis of unknown origin in children
19 April 2022 - Following the reports of cases of acute hepatitis of unknown origin by the UK Health Security Agency, additional cases in children have been reported in Denmark, Ireland, the Netherlands, and Spain.
In addition, nine cases of acute hepatitis among children between 1 and 6 years old in the state of Alabama in the United States who also tested positive for adenovirus have been reported.
Garcelle Beauvais of Real Housewives is Also a Longtime HIV Advocate
APRIL 18 2022 - By Neal Broverman - The Haitian-born actress and model has long been using her platform to make the world a better place, including for those living with HIV.
After moving from Haiti as a teenager, Garcelle Beauvais almost instantly starting working, snagging modeling jobs and roles on Miami Vice and Coming to America. She would become a mainstay of TV in the 1990s, with roles on The Jamie Foxx Show and NYPD Blue. Now, the mom of three is juggling a podcast (Going to Bed with Garcelle), cohosting the popular talk show The Real, and making history as the first Black cast member of The Real Housewives of Beverly Hills. In between, Beauvais finds time for philanthropy, including Black and HIV causes. Here’s how she balances it all:
Read more...
Greg Louganis: Catching Up with the Long-Term HIV Survivor
APRIL 18 2022 - By Jeffrey Masters - "I didn't think I'd see 30, honestly," the four-time Olympic gold medal-winner says.
The next time you think about what HIV looks like, think about Greg Louganis winning two Gold medals at the 1988 Olympics in Seoul.
He became the first man and only the second diver in Olympic history to sweep both diving events in two consecutive Olympics — and he did it six months after learning that he was living with HIV. Louganis was taking AZT at the time, setting his alarm for every four hours, even waking up in the middle of the night during the competition to take the medication.
Read more...
Service Member Discusses Historic Win in His Fight Against the Military’s HIV Ban
April 18, 2022 - Tim Murphy - Since the 1980s, the U.S. military has banned folks with HIV from enlisting—and barred folks already in the military who test positive for HIV from deploying. Consequently, the ban has blocked those with HIV from being commissioned as officers and advancing in their careers. The policy has long been protested by HIV and LGBTQ activists, especially once HIV became a chronic manageable illness in the 21st century—and more so once it was learned that folks with HIV on meds who have an undetectable viral load can’t even transmit the virus. But the military kept the policy in place.
Read more...
Can HIV cure trials strike a balance between the need for meaningful data and participant safety?
18 April 2022 - Andy Carstens - A recent analysis indicates that HIV cure trials thus far haven’t included enough participants to detect when treatments provide moderate benefits. As a result, researchers may be missing opportunities to study and improve upon drug combinations that could eventually lead to a cure. Dr Jillian Lau, Dr Deborah Cromer and colleagues, whose analysis was published in The Journal of Infectious Diseases, propose a hybrid trial design that would maximise the potential of finding treatment benefits while minimising participant risk.
Read more...
Global study finds increase in deaths from COVID-19 at the weekend
April 16, 2022 - Worldwide analysis of nearly 6 million deaths from COVID-19 over 2 years finds an increase in COVID-19 mortality at weekends compared to weekdays.
The average number of global deaths from COVID-19 were 6% higher on weekends compared to weekdays (8,532 vs 8,083) throughout the pandemic, according to new research analysing all deaths reported to the WHO COVID-19 database between March 7, 2020 and March 7, 2022. The study is by Dr. Fizza Manzoor and Dr. Donald Redelmeier from the University of Toronto, Canada.
Estudo global constata aumento de mortes por COVID-19 nos fins de semana
16 de abril de 2022 - A análise em escala mundial de quase 6 milhões de mortes por COVID-19 ao longo de 2 anos constata um aumento na mortalidade por COVID-19 nos fins de semana em comparação com os dias de semana
O número médio global de mortes por COVID-19 foi 6% maior nos fins de semana em comparação com os dias úteis (8.532 x 8.083) durante a pandemia, de acordo com uma nova pesquisa que analisa todas as mortes relatadas ao banco de dados da COVID-19 da OMS entre 7 de março de 2020 e 7 de março de 2022. O estudo é da Dra. Fizza Manzoor e do Dr. Donald Redelmeier, da Universidade de Toronto, Canadá.
NIH Grant Awarded to Study HIV Drug-Resistant Genetic Mutations Across Africa
14-Apr-2022 - Newswise - University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV) researchers received funding from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for $2.7 million to study genetic changes in two genes from the HIV-1 virus that may make it resistant to antiretroviral therapy. The study, named INSPIRE, will analyze genetic variation in types of HIV circulating in a handful of African countries that will help to better understand the implications of these mutations and will improve clinical management of patients.
National Transgender HIV Testing Day 2022
APRIL 14, 2022 - April 18 is NATIONAL TRANSGENDER HIV TESTING DAY 2022
On April 18, AIDSVu recognizes National Transgender HIV Testing Day (NTHTD), a day to shed light on the disproportionate impact of HIV on the transgender community and to promote HIV testing, prevention, and care among transgender and gender non-binary people.
HIV Criminalization Laws and Race Combine To Make The Perfect Storm in Georgia
April 13, 2022 - Darian Aaron - Imagine having to process the life-altering news that you’ve acquired HIV. Now imagine that your new health status can be weaponized against you, setting the stage for a felony conviction with a penalty of up to ten years in prison. The premise may sound like the story arc of a screenplay, but for Georgians living with HIV, the possibility of entering the criminal justice system because of HIV-related offenses is real, even more so if you’re Black, a sex worker, or identify as LGBTQ.
Read more...
HIV Hides in Immune System Cells Resistant to Killer T Cells
APRIL 13, 2022 - Scientists have known for years that HIV, the virus that causes AIDS, is difficult to cure because it hides from the body’s immune system. Research now reveals that the virus conceals itself in lymphocytes, or white blood cells, that are intrinsically hard to kill because they are resistant to killer T cells, according to a new study by Weill Cornell Medicine investigators.
Increase in acute hepatitis of unknown origin among children – United Kingdom
13 April 2022 - ECDC has been informed of an increase in acute hepatitis cases in children during the past few weeks in the United Kingdom (UK) and is sharing this information internationally to increase awareness among clinicians taking care of children, to determine whether there are any similar cases in other countries.
The clinical syndrome in identified cases is of severe acute hepatitis with markedly elevated transaminases, often presenting with jaundice, sometimes preceded by gastrointestinal symptoms including vomiting as a prominent feature, in children up to the age of 16 years.
Widely Used Meds Linked to Falls and Frailty in Older People With HIV
April 13, 2022 - By Liz Highleyman - Anticholinergic medications can lead to cognitive problems and poor coordination, especially in older people.
A widely used class of medications may increase the risk of recurrent falls and frailty in older people living with HIV, according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2022).
Read more...
People at risk of future heart disease and stroke may be at greater risk for severe COVID-19
April 13, 2022 - Study in almost a million adults in England finds that people at risk of heart attack or stroke over the next 10 years (but without existing cardiovascular disease) are at substantially greater risk of becoming seriously unwell with COVID-19
New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April), suggests that people with elevated risk of developing a stroke or heart attack over the next 10 years (but without existing cardiovascular disease [CVD]) who contract COVID-19, are nearly three times as likely to be hospitalised and require treatment in intensive care, and six times as likely to die from COVID-19, compared to those at low cardiovascular risk.
UNAIDS warns that the war in Ukraine risks a humanitarian catastrophe for people living with and affected by HIV
GENEVA, 13 April 2022 - Urgent call issued for a dramatic upscaling of international support for the heroic efforts of civil society-led networks to reach people with life-saving HIV treatment
The war in Ukraine has resulted in the destruction and disruption of health services and logistical supply chains that hundreds of thousands of people living with and affected by HIV depend on for survival. One in every 100 Ukrainians are living with HIV, and lack of access to antiretroviral therapy and prevention services would mean a wave of deaths and risks a resurgence of Ukraine’s AIDS pandemic. The community-led networks which are vital to maintaining life-saving services need an urgent upscaling of international support.
More than 40 health facilities that offered HIV treatment, prevention and care services before the war are now closed and there are various levels of service disruption at other sites.
HPV increases the risk of HIV acquisition among women in sub-Saharan Africa
13 April 2022 - Edith Magak - A study by Dr Gui Liu of the University of Washington, Seattle and colleagues published in the journal AIDS found that among women in sub-Saharan Africa, the risk of HIV acquisition increased with the number of human papillomavirus (HPV) infections. With each additional HPV type detected, HIV risk increased by 20%.
Read more...
THE LANCET INFECTIOUS DISEASES: Threat of untreatable gonorrhoea could be tackled using an existing meningitis vaccine
12-APR-2022 - THE LANCET - Meningitis vaccines could help improve protection against gonorrhoea amid rising cases globally and increasing bacterial resistance to drugs used to treat the infection, according to findings from three linked papers published in The Lancet Infectious Diseases journal.
HIV: THE ANTIBODIES OF "POST-TREATMENT CONTROLLERS"
2022.04.12 - A very small percentage of people with HIV-1 and who received early treatment maintained over several years have the capacity to control the virus over the long-term when their treatment is interrupted. However, the mechanisms of this control have not been fully elucidated.
The Folly of World-Wide Covid Vaccination
April 11, 2022 - By Allysia Finley - The pandemic stole focus from other, deadlier diseases, including HIV/AIDS in the developing world.
President Biden is asking Congress for $5 billion to pay for a global Covid vaccination campaign. The goal, set by the World Health Organization, is to vaccinate 70% of the population in every country. But other infectious diseases that are much deadlier than Covid in low-income countries have taken a back seat during the pandemic. It’s time to reset public-health priorities.
Read more...
New study from UCI reveals how to rejuvenate the immune system of elderly people and reduce their risk of infectious disease
Irvine, CA – April 11, 2022 - Results identify reason for why older adults are significantly more susceptible to infectious diseases
A new study, led by researchers from the University of California, Irvine, identifies a reason for why older adults are significantly more susceptible to infectious diseases than younger people, a critical societal issue most recently exemplified by the COVID-19 pandemic.
Study results also pave the way for new potential therapeutic targets to rejuvenate the immune system in older adults and thereby reduce their risk of infectious disease.
New approach for delivery of anti-HIV antibody therapy shows promise in phase I clinical trial
APR 11, 2022 - BOSTON - Since the first reports of HIV infection in the early 1980s, multiple clinical trials have tested potential vaccines against the virus, but unfortunately, HIV has numerous defense mechanisms that prevent a person’s immune system from mounting an effective response following HIV vaccination. An alternative anti-HIV strategy called Vectored ImmunoProphylaxis (VIP) designed by researchers at the Ragon Institute of MGH, MIT and Harvard and Massachusetts General Hospital (MGH) involves an adeno-associated viral (AAV) vector to deliver instructions to muscle cells to pump out antibodies that block the virus. The strategy recently generated promising results in a phase I clinical trial that was conducted by the National Institutes of Health and is published in Nature Medicine.
Art For Life
May 26th, 2022 - 6:30pm until late - Imperial Vancouver
Join us on May 26th as we bring together some of Vancouver's most talented artists all in support of the Dr. Peter Centre's Art Therapy Program.
Support the Centre by bidding on artwork that has been chosen and curated by art connoisseurs and experts.
Funds raised will directly support the Art Therapy Program at the Dr. Peter Centre. Art for Life is an opportunity to support compassionate care for those in our community living with HIV. We work with individuals who are at the intersection of mental illness, substance use, poverty, HIV and chaotic living situations.
POZ Cruise
NOVEMBER 3 - 13, 2022
Our 17th Cruise For People Living with HIV! Men, Women, Family & Friends Invited. Gay & Straight! Over 200 Expected!
This is the 17th cruise we are running for people living with HIV. The cruise is open to men and women, gay and straight, as well as family and friends. Cabin shares available. Over 200 expected!
Sail from Fort Lauderdale on the Caribbean Princess to Falmouth (Jamaica), Cartagena (Colombia), The Panama Canal, Limon (Costa Rica), and Grand Cayman Island! Enjoy Four Fun–filled days at sea with special events. Or you can just relax. It's your Retreat to do as you please.
Meningococcal Disease Outbreak, Florida, 2022
APRIL 9, 2022 - Get Vaccinated
There is a large, ongoing outbreak of meningococcal disease in Florida, primarily among gay, bisexual, and men who have sex with men, including those living with HIV. There have also been cases reported in the state over the last few months, including multiple cases in college students. At this time, there is no evidence to suggest that the cases among college students are related to the larger outbreak.
Don’t compound tragic effect of COVID-19 on HIV
04/09/22 - BY CARL SCHMID - The silent tragedy of the COVID-19 pandemic is its devastating impact on people with other health conditions. For those illnesses, declining attention has persisted even as the threat of COVID-19 is declining.
HIV provides a striking example of the setback — and how the effects are looming in the shadows.
Read more...
STIs spreading aggressively in Canada as testing, prevention abandoned during pandemic
04/09/22 - ZOSIA BIELSKI - After gonorrhea cases spiked during the pandemic in New Brunswick – jumping nearly fivefold between 2020 and 2021, then tripling in the first months of this year compared with last – public health officials took to TikTok, Instagram and dating site Tinder with a cautionary campaign.
Read more...
New tool reveals how immune cells find their targets
APRIL 8, 2022 - Anne Trafton | MIT News Office - MIT biological engineers have developed a simple way to identify B or T cells that interact with viral or bacterial proteins.
The human body has millions of unique B and T cells that roam the body, looking for microbial invaders. These immune cells’ ability to recognize harmful microbes is critical to successfully fighting off infection.
MIT biological engineers have now devised an experimental tool that allows them to precisely pick out interactions between a particular immune cell and its target antigen. The new technique, which uses engineered viruses to present many different antigens to huge populations of immune cells, could allow large-scale screens of such interactions.
National Youth HIV/AIDS Awareness Day 2022
APRIL 7, 2022 - April 10 is National Youth HIV/AIDS Awareness Day (NYHAAD)
April 10 is National Youth HIV/AIDS Awareness Day (NYHAAD), a day to educate the public on the impact of HIV on youth, especially young people of color. This NYHAAD, we recognize the resilience of youth and young leaders fighting the HIV epidemic across the country as they highlight the urgent need to raise awareness about HIV prevention and care among their peers.
Federal Court Strikes Down Pentagon’s Discriminatory Restrictions on Military Service of People Living with HIV as Arbitrary and Unconstitutional; Hailed by Lambda Legal as “Landmark Victory
APRIL 7, 2022 - “The court ruled that the Pentagon’s policies regarding service members with HIV are not only outdated, but unlawful, arbitrary and capricious, and unconstitutional . . . one of the strongest judicial rulings in over two decades..."
Yesterday, a federal district court handed down of the strongest judicial rulings in over two decades for people living with HIV, ordering the Department of Defense (DOD)—the world’s largest employer—to stop discriminating against people living with HIV and to allow them to deploy and commission as officers in the U.S. military. The groundbreaking ruling represents a landmark moment in the fight to advance the rights of people living with HIV and reflects the reality that HIV is a chronic, treatable condition, not a reason to discriminate. The ruling comes in two cases Harrison v. Austin and Roe & Voe v. Austin, combined for purposes of discovery and argument – for which Lambda Legal is co-counsel with Scott Schoettes, Esq., Peter Perkowsky, Esq., Winston & Strawn LLP, and Greenberg Traurig LLP.
Payment shapes research participation decisions
APRIL 7, 2022 - by IQBAL PITTALWALA - Study used data from a national survey of people living with HIV
Payment plays a major role in research participation decisions, a study on participation in HIV research has found.
“Payment is a key part of research participants risk-benefit calculation when joining a study, with most people agreeing people should be paid,” said Brandon Brown, an associate professor of social medicine, population, and public health in the UC Riverside School of Medicine and the study’s principal investigator. “We need to explore this topic further and ensure that researchers, institutional review board members, and study participants are on the same page on payment to ensure research success.”
40th Anniversary of the HIV/AIDS Epidemic: The Current State in San Francisco
APRIL 7, 2022 - by Eduardo Morales, Ph.D. - The Centers for Disease Control and Prevention first reported the initial cases of HIV/AIDS in the U.S. during June of 1981. In the recent release of the 2020 Annual Report by the San Francisco Department of Public Health (SFDPH), gradual declines in new HIV/AIDS cases were noted. The data, however, was compromised by the lack of public access to HIV testing during the COVID-19 pandemic. A rally was held on the steps of SF City Hall on Monday, March 21, and called on San Francisco leaders to take back HIV as a major priority. San Francisco employed strategies to respond to COVID-19 built upon novel comprehensive approaches used for HIV/AIDS. Meanwhile, the SFDPH 2020 Annual Report notes important differences by ethnicity and race.
Accessible Care Key to Treating Hepatitis C in People Who Inject Drugs
APRIL 7, 2022 - Among participants who had hepatitis C and who injected drugs, those treated at a non-stigmatizing “accessible care” treatment center co-located with a syringe service program (SSP) were nearly three times more likely to be cured of the infectious disease compared with those referred out to local clinicians through patient navigation, according to a randomized clinical trial led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, NYU Grossman School of Medicine, and the CUNY Graduate School of Public Health and Health Policy. It is estimated that more than 80 percent of people with hepatitis C in the United States presently inject drugs, so the results suggest that expanding and supporting the accessible care model could be instrumental in eliminating the disease.
UNAIDS strengthens partnership with Germany and opens a new office in Bonn
GENEVA, 7 April 2022 - The German Federal Government has agreed to host a new UNAIDS office in Bonn. The agreement is part of Germany’s commitment to reinforce its partnership with the United Nations and part of UNAIDS’ commitment to realign its work to the new Global AIDS Strategy 2021–2026: End Inequalities, End AIDS.
“UNAIDS welcomes this important support by Germany,” said Winnie Byanyima, Executive Director of UNAIDS. “Germany is continuing to demonstrate its commitment to end AIDS through shared responsibility and global solidarity, and we look forward to working ever more closely into the future towards our common goals.”
Innovative Clinical Strategies to Treat HIV and Cancer Presented by Pioneering Research Scientist at the Innate Killer Summit in San Diego
LOS ANGELES, April 6, 2022 /PRNewswire/ -- Dr. Serhat Gumrukçu, inventor and co-founder of Enochian BioSciences and Director of Research at the Seraph Research Institute, was invited to present his innovative clinical strategies to treat HIV and Cancer at the Innate Killer Summit in San Diego, California. The presentation, delivered as the closing Plenary Lecture, was based on Dr. Gumrukçu's promising clinical strategies designed to hyper stimulate various components of the immune system, including those that are part of innate killer immunity.
AIDSWatch participants push for congressional action to end HIV epidemic
WASHINGTON, April 6, 2022 - AIDSWatch 2022 ended Wednesday after three days of virtual plenaries, workshops and meetings with congressional offices.
AIDSWatch is the largest national, constituent-led HIV advocacy event in the country.
South Florida seeing an uptick in HIV diagnoses among people 50 and older
April 6, 2022 - By Verónica Zaragovia - Miami Dade and Palm Beach are two of the counties in Florida seeing increases in the rates of people 50 and older who are testing positive for HIV. Experts say doctors and patients alike should consider the importance of safe sex education and testing for the virus among older people, too.
Read more...
Kaposi Sarcoma Still a Major Contributor to Morbidity, Mortality in Certain HIV Populations
APRIL 6, 2022 - By Leah Lawrence - Kaposi sarcoma (KS) continues to play a significant part in morbidity and mortality among Black patients with HIV living in the South.
Read more...
UM School of Medicine Institute of Human Virology’s Robert Gallo Receives Distinguished Alumni Award by the University of Chicago Medical Association
April 05, 2022 - Nora Samaranayake - Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and Chair of the Scientific Leadership Board of the Global Virus Network, was awarded the Distinguished Alumni Award by the University of Chicago Medical & Biological Sciences Alumni Association (UChicago MBSAA) for his lifetime achievements. Honorees will participate in a panel discussion on May 10 and will be presented the award on May 21 at the Hyde Parke campus.
Health partners race to secure life-saving HIV medicines and services for people affected by the war in Ukraine
GENEVA, 5 April 2022 - As shipments of antiretroviral treatment arrive, challenges are mounting to ensure it reaches those in need
The war in Ukraine has resulted in a catastrophic humanitarian crisis with rapidly growing numbers of deaths and casualties, the destruction of entire cities and towns and unconscionable attacks on health facilities and other civilian targets. This is putting Ukrainians living with HIV in grave danger.
“It is becoming increasingly difficult for people to access the health care they need, including services for HIV,” said Winnie Byanyima, Executive Director of UNAIDS. “UNAIDS estimates that 260 000 people were living with HIV in Ukraine before the war broke out, 152 000 of whom were taking daily medication for HIV. There is no cure for HIV. Without access to antiretroviral medicines people living with HIV will die.”
Get your taste buds ready for ARCH's Taste For Life
Apr 5, 2022 - Santana Bellantoni - ARCH has already raised $16,000 through the Taste For Life fundraiser
A Taste For Life fundraiser is up and running this month to help raise money for HIV/AIDS resources for ARCH.
ARCH said this is their biggest fundraiser of the year which helps efforts from ARCH to support individuals in the community who live with HIV.
Read more...
Recalling One Activist Group’s Outraged Art at the Height of the AIDS Crisis
April 5, 2022 - By Alexandra Jacobs - “It Was Vulgar & It Was Beautiful,” by Jack Lowery, recounts the daring efforts of Gran Fury to bring attention and resources to the cause.
The revolution would not be televised, but slathered with wheat paste.
Do not underestimate the importance of this starchy makeshift adhesive in the history of AIDS awareness — back when a “poster” was not someone writing anonymous comments online but public relations on paper, in the actual town square.
Read more...
Why a Healthy Diet is Vital for People Living with HIV
April 5, 2022 - By Neal Broverman - Healthy eating habits are important for everyone — but especially those living with HIV, according to the latest data.
The south African nation of Zimbabwe made significant strides against HIV in recent years, with local reports indicating nearly three-quarters of people living with the disease are now on antiretroviral medication. But there is an obstacle to better health outcomes for individuals on treatment, at least according to Moreni Masanzu of the Zimbabwe National Network of People Living With HIV: nutrition.
Read more...
Russian HIV Charities Face Funding, Supply Crisis
April 5, 2022 - Under shelling and missiles, medics risk their lives to treat the 250,000 people in Ukraine with HIV amid fears that the war could set their efforts back decades, reports Bel Trew from Odesa and Zaporizhzhia
Western sanctions and an economic crisis resulting from the invasion of Ukraine are hindering Russia’s HIV/AIDS charities, activists and campaigners say, in what risks worsening an already grave epidemic.
Read more...
Ukraine has one of the highest HIV rates in Europe. Russia’s war could set back fight against virus 20 years
April 5, 2022 - Bel Trew - Under shelling and missiles, medics risk their lives to treat the 250,000 people in Ukraine with HIV amid fears that the war could set their efforts back decades, reports Bel Trew from Odesa and Zaporizhzhia
The shelling is so intense that on bad days it turns the sky orange. But despite this, Iryna Bondarenko and her team get in their cars and drive through the explosions to deliver life-saving medicines and services to those living with HIV in Ukraine.
Read more...
Health partners race to secure life-saving HIV medicines and services for people affected by the war in Ukraine
GENEVA, 5 April 2022 - As shipments of antiretroviral treatment arrive, challenges are mounting to ensure it reaches those in need
The war in Ukraine has resulted in a catastrophic humanitarian crisis with rapidly growing numbers of deaths and casualties, the destruction of entire cities and towns and unconscionable attacks on health facilities and other civilian targets. This is putting Ukrainians living with HIV in grave danger.
“It is becoming increasingly difficult for people to access the health care they need, including services for HIV,” said Winnie Byanyima, Executive Director of UNAIDS. “UNAIDS estimates that 260 000 people were living with HIV in Ukraine before the war broke out, 152 000 of whom were taking daily medication for HIV. There is no cure for HIV. Without access to antiretroviral medicines people living with HIV will die.”
Holy Cross to Name Science Complex for Dr. Anthony Fauci ‘62
April 4th, 2022 - by College of the Holy Cross - Fauci, a classics major, has led the nation’s response to health crises for nearly four decades
The Integrated Science Complex at College of the Holy Cross will be renamed this summer in honor of Dr. Anthony Fauci, one of the college’s most prominent alumni, Holy Cross President Vincent D. Rougeau announced Monday.
The animal origin of major human infectious diseases: What can past epidemics teach us about preventing the next pandemic?
4- Apr-2022 - COMPUSCRIPT LTD - Announcing a new article publication for Zoonoses journal.
Emerging infectious diseases are one of the greatest public health challenges. Approximately three-quarters of these diseases are of animal origin. These diseases include classical zoonoses maintained in humans only via transmission from other vertebrates (e.g., rabies) and those initiated by a successful one-off zoonotic event (host-switch) in conjunction with efficient human-to-human transmission (e.g., H1N1 influenza).
HIV drug stabilizes disease progression in metastatic colorectal cancer
APR 4, 2021 - BOSTON - New clinical research shows that lamivudine, a reverse transcriptase inhibitor widely used in HIV therapy, stopped disease progression in 25% of patients with fourth-line metastatic colorectal cancer. Findings from the trial, published in Cancer Discovery, raise the possibility of an unexpected promising direction in cancer treatment, not just colorectal cancer.
Ukraine war: Tens of thousands of people with HIV 'at risk' as medicine delivery disrupted by Russian attacks, charity says
3 April 2022 - By Scott Beasley - The lives of tens of thousands of people with HIV in Ukraine are now at risk as the war has stopped lifesaving drugs reaching those who need them, an expert on the ground has told Sky News.
Andriy Klepikov, from the Alliance for Public Health, told Sophy Ridge on Sunday that "59,000 people are on antiretroviral therapy in areas affected by the war, and less than 40% managed to move outside of the war zones so we are talking about tens of thousands of people at risk".
Read more...
World’s Third AIDS Patient Cured
04/03/2022 - By Kambiz Shekdar, Ph.D. - What Does it Mean for a Global Cure?
Within the research community, the Holy Grail to cure AIDS had been to find new drugs to “Shock and Kill” the festering virus from its hiding places (“latent infections” and “viral reservoirs”). No such drugs have been developed, yet three persons have been cured using highly imaginative stem cell strategies. The most recent stem cell cure reported in February 2022 is beginning to cause the field to re-think and expand strategies to develop a global cure, including new initiatives by NIH.
Read more...
Elton John thanks family of Ryan White, brave teen who died of AIDS in 1990, for saving his life
APR 02, 2022 - By MURI ASSUNÇÃO - Elton John honored the family of Ryan White, the Indiana teen who fought against AIDS stigma in the late ‘80s, and thanked them for saving his life, during a concert Friday night.
Read more...
More girls, young women contracting HIV/Aids
APR 02, 2022 - by Chulumanco Mahamba - The Basic Education Department has launched an initiative in response to the urgent need to address the alarming number of adolescent girls and young women contracting and dying from HIV/Aids.
The Deputy Minister of Basic Education Dr Reginah Mhaule yesterday (Thurs) launched the Education Plus Initiative in partnership with the UN and the South African National Aids Council (Sanac).
Read more...
bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test
Richmond, B.C., April 01, 2022 - bioLytical Laboratories Inc. announced today that it is launching a second test on its new platform, iStatis, after receiving Health Canada authorization for the iStatis COVID-19 Antigen Home Test for its immediate market entry into Canada
bioLytical Laboratories Inc. (“bioLytical”), a global leader in rapid in-vitro medical diagnostics, announced today that it is launching its iStatis COVID-19 Antigen Home Test after receiving Health Canada Interim Order authorization, allowing its immediate entry into the Canadian market.
Building on its innovative INSTI® testing platform, the iStatis COVID-19 Antigen Home Test is on bioLytical’s newest platform, iStatis. With this additional lateral flow diagnostic technology, bioLytical can continue to reach more people, helping to provide peace of mind to Canadians looking to make informed health choices.
CRISPR and HIV: New technique in human blood unveils potential paths toward cure
April 01, 2022 - By Win Reynolds - Key to possible HIV cure may lie in mechanisms behind how it replicates
Scientists at Northwestern Medicine are using new advances in CRISPR gene-editing technology to uncover new biology that could lead to longer-lasting treatments and new therapeutic strategies for Human Immunodeficiency Virus (HIV).
The HIV epidemic has been overlooked during the COVID-19 pandemic but represents a critical and ongoing threat to human health with an estimated 1.5 million new infections in the last year alone.
Researchers Identify Sustainable Source of Immunodeficiency Virus-resistant Immune Cells
1 April, 2022 - May unlock alternative approaches to treating HIV
Genetic engineering can make immune cells resistant to infection with human or monkey (simian) immunodeficiency virus (HIV and SIV, respectively). Recently, treatment with HIV-resistant immune cells has given encouraging results in patients. Stem cell researchers have now found ways of making large numbers of virus-resistant immune cells from monkeys, allowing future studies on safety and efficacy of immune therapy in a pre-clinical animal model. This encouraging research, recently published in Stem Cell Reports, will help scientists consider alternative approaches to treating HIV, the virus causing AIDS.
|
